Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 839-846

  Kim, Mi Suk ^a,c   Park, Myung Jin ^b   Kim, So Jeong ^a   Lee, Chang Hun ^a   Yoo, Heon ^a   Shin, Sang Hoon ^a   Song, Eun Sook ^c   Lee, Seung Hoon ^a  

^a National Cancer Center   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

Emodin; Glioma; Hyaluronic acid; Invasion; Matrix metalloproteinase

Indexed keywords

AKT1 PROTEIN, HUMAN; EMODIN; ENZYME INHIBITOR; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 1; GELATINASE A; GELATINASE B; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PTK2 PROTEIN, HUMAN; PTK2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR AP 1;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER INVASION; CELL MOTION; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; EMODIN; ENZYME INHIBITORS; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; HYALURONIC ACID; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 24344487224     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Johnsen M, Lund LR, Romer J, Almholt K, et at. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667-671, 1998.
2. Sappino AP, Huarte D, Belin D and Vassalli JD: Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J Cell Biol 109: 2471-2479, 1989.
3. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
4. Bohle AS and Kalthoff H: Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 384: 133-140,1999.
5. Sugiura Y, Shimada H, Seeger RC, et al: Matrix metalloproteinases- 2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 58: 2209-2216, 1988.
6. Montgomery AM, Mueller BM, Reisfeld RA, et al: Effect of tissue inhibitor of the matrix metalloproteinase-2 expression on growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467-5473, 1994.
7. Nagase H and Woessner JF: Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
8. Tonn JC, Kerkau S, Hanke A, et at. Effect of synthetic matrixmetalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer 80: 764-772 1999.
9. Watanabe K, Yoshida D, Nona M, et at. Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B. J Neurooncol 52: 1-9,2001.
10. Von Deimling A, Louis DN and Weiestler OD: Molecular pathways in the formation of gliomas. Glia 15: 328-338, 1995.
11. Nakano A, Tani E, Miyazaki K, et at. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307, 1995.
12. Lampert K, Machein U, Machein MR, et at. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 153: 429-437, 1998.
13. Knudson W: Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am J Pathol 148: 1721-1726, 1996.
14. Lokeshwar VB, Obek C, Soloway MS, et at. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 57: 773-777, 1997.
15. Nakagawa T, Kubota T, Kabuto M, et at. Hyaluronic acid facilitates glioma cell invasion in vitro. Anticancer Res 16: 2917-2922, 1996.
16. Merzak A, Koocheckpour S and Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54:3988-3992, 1994.
17. Park MJ, Kim MS, Park IC, et at. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res 21: 6318-6322, 2002.
18. Koyama M, Kelly TR and Watanabe KA: Novel type of potential anticancer agents derived from chrysophanol and emodin. J Med Chem 31: 283-284, 1988.
19. Huang HC, Chu SH and Chao L: Vasorelaaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties, Eur J Pharmacol 198:211-213, 1991.
20. Zhang L and Hung MC: Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene 3: 571-576, 1996.
21. Chang LC, Sheu HM, Huang YS, et at. A novel function of emodin: enhancement of the nucleotide excision repair of UVand cisplatin-induced DNA damage in human cells. Biochem Pharmacol 58: 49-57, 1999.
22. Huang Q, Shen HM and Ong CN: Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem Pharmacol 68: 361-371, 2004.
23. Thant AA, Nawa A, Kikkawa F, et at. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the P13K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis 18:423-428, 2000.
24. Kurata H, Thant AA, Matsuo S, et at. Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. Exp Cell Res 254: 180-188, 2000.
25. Kim D, Kim S, Koh H, et at. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15: 1953-1962, 2001.
26. Yokoo T and Kitamura M: Dual regulation of IL-IB-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-KB and AP-1. Am J Physiol 270: F123-F130, 1996.
27. Pedersen P, Ness G, Engebraaten O, et at. Heterogeneous response to the growth factors [EGF, PDGF, TGF-alpha, bFGF, 11-12] on glioma spheroid growth, migration and invasion. Int J Cancer 56: 225-261, 1994.
28. Bernstein J, Laws E, Levine K, et at. C6 glioma-astrocytoma cell and fetal astrocyte migration into artificial basement membrane: a permissive substrate for neural tumors but not fetal astrocytes. Neurosurgery 28: 652-658, 1991.
29. Zhang L, Lau YK, Xi L, et at. Tyrosine kinase inhibitor, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene 4: 2855-2863, 1998.
30. Mignatti P and Rifkin DB: Biology of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
31. Westermarck K and Kähäri VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
32. Benbow U, Schoenermark MP, Mitchell TI, et al: A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem 274:25371-25378,1999.
33. Vince GH, Wagner S, Pietsch T, et at. Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas. Int J Dev Neurosci 17: 437-445, 1999.
34. Uhm JH, Dooley NP, Villemure JG, et al: Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can J Neurol Sci 24: 3-15, 1997.
35. Gum R, Wang H, Lengyel E, et at Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14: 1481-1493, 1997.
36. Aguirre Ghiso JA, Alonso DF, Farias EF, et at. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem 263: 295-304,1999.
37. Lakka SS, Jasti SL, Gondi C, et at. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21: 5601-5608, 2002.
38. Park ML Park IC, Hur JH, et at. Modulation of phorbol esterinduced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase. J Neurosurg 97: 112-118, 2002.
39. Kubiatowski T, Jang T, Lachyankar MB, et at. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg 95: 480-488, 2001.
40. Kumar A, Dhawan S and Aggarwal BB: Emodin (3-methyl-l, 6, 8-trihydroxyanthraquinone) inhibits TNF-induced NFkappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 17: 13-18, 1998.